Richard Anderson, Crawford Healthcare
Crawford Healthcare, the advanced wound care company, has announced a significant milestone for its U.S. business, Crawford Healthcare Inc.
The company has received an innovative technology contract for its Touchless Care Zinc Protectant Spray from Vizient, Inc., based on a recommendation of Touchless Care by hospital experts.
Vizient reserves its Innovative Technology contracts for technologies that demonstrate an ability to enhance clinical care or patient safety, and those that improve an organisation’s care delivery and business model.
Touchless Care Zinc Oxide Protectant Spray is a unique product designed to treat incontinence associated dermatitis, commonly referred to as nappy rash. Its formula of 25% Micro-fine Zinc and 20% Dimethicone, coupled with its differentiated application process, helps clinicians and patients by improving clinical outcomes, reducing pain, saving time, supplies and waste.
Dave Posten, V.P. sales and U.S. commercialization. “Crawford Healthcare is excited about the opportunity to work with the Vizient membership and to offer enhanced savings on a product that helps treat a condition that patients and clinicians don’t always want to talk about.
“This product’s ability to increase patient dignity, reduce pain and help a nurse improve outcomes is a prime example of why we are passionate about our company, our jobs and our products. This innovative technology contract demonstrates Crawford’s ability to bring unique and outcomes driven products to the U.S. market.”
Richard Anderson, Crawford CEO, added: “This is another success for our U.S. business and testament to our world class products and people. We look forward to a long and successful relationship with Vizient.”
“Due to the number of products and services being released and marketed as ‘innovative’, member hospitals truly value the thorough review process in place at Vizient to help them identify products worth further evaluation at their own facilities,” said Debbie Archer, director of procurement and leader of Vizient’s Innovative Technology programme for suppliers. “After a full review of Touchless Care Zinc Protectant Spray, Vizient’s member council agreed this solution offers unique and incremental benefit over other products available on the market today, and recommended it for an Innovative Technology contract. We are pleased to award this new contract to Crawford Healthcare.”
This latest agreement furthers Crawford position in increasing its international share of a global wound care market expected to reach $22billion (USD) by 2022.